|
Online CME Activity
Factors that Influence Patients' Use of Asthma Medications
|
NOTE: Although this activity is no longer certified for credit, we believe that it contains important information and hope you’ll review, print or email it to a colleague.
Factors that Influence Patients' Use of Asthma Medications
Immunology, Asthma, Respiratory
1.00 AMA PRA Category 1 Credits™
Learning Objective
Participants should be able to highlight at least 2 key findings of the study presented in this activity and discuss the applicability of these findings to clinical practice.
Accreditation
This educational program is conceived and credited in accordance with ACCME’s Essential Areas and Policies, including the 2004 Updated Standards for Commercial Support. Pri-Med faculty hail from a variety of institutions and participate in content development, along with Pri-Med Institute’s Advisory Boards and its expert review partners, the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute. All final decisions about program content are the responsibility of Pri-Med Institute.
| Credits |
Type |
Accreditation Statement |
Designation Statement |
| 1.00 |
AMA PRA Category 1 Credits™ |
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
Pri-Med Institute designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
Faculty and Editorial Board
Written By:
David P. Skoner, MD, Director, Division of Allergy, Asthma, and Immunology, Dept of Pediatrics, Allegheny General Hospital, Pittsburgh, PA;
Edited By:
Jean Baker, MS, RD, Clinical Editor, Pri-Med Institute, Boston, MA;
Financial Disclosure Statement(s)
Dr Skoner has served on the speakers bureaus for AstraZeneca Pharmaceuticals LP; sanofi-aventis U.S.; GlaxoSmithKline; Merck & Co., Inc.; Schering-Plough Corporation; and Novartis Pharmaceuticals Corporation. He has received grant support from AstraZeneca Pharmaceuticals LP; sanofi-aventis U.S.; GlaxoSmithKline; Novartis Pharmaceuticals Corporation; and Merck & Co., Inc. He has served as a consultant to Merck & Co., Inc.
Ms Baker has no financial relationships to disclose.
Education Partner:
Health Education Alliance
Commercial Support:
Schering-Plough Corporation
Pri-Med Disclaimer
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, or M|C Communications, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.
|
|
|
